Alpha Tau Medical (DRTS) Treasury Shares (2020 - 2023)
Alpha Tau Medical (DRTS) posted Treasury Shares of $747506.0 for Q4 2025, down 38.28% sequentially from $1.2 million in Q2 2025, and down 12.87% YoY from $857899.0 in Q4 2024.
Analysis
Alpha Tau Medical (DRTS) Treasury Shares (2020 - 2023) Analysis & Trends
Alpha Tau Medical has reported Treasury Shares for 6 years, with the latest figure at $747506.0 in Q4 2025.
- Quarterly Treasury Shares fell 12.87% year-over-year to $747506.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $747506.0 (down 12.87% YoY) and the FY2025 annual result came in at $747506.0, down 12.87% from the prior year.
- Treasury Shares declined to $747506.0 in Q4 2025 per DRTS's latest filing, from $1.2 million in the prior quarter.
- Over five years, Treasury Shares peaked at $13.7 million in Q4 2021 and troughed at $747506.0 in Q4 2025.
- A 5-year average of $2.8 million and a median of $924867.0 in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2021 and 2022: Treasury Shares jumped 90.03% in 2021, then plunged 93.27% in 2022.
- Over 5 years, Treasury Shares stood at $13.7 million in 2021, then slumped by 93.27% to $924867.0 in 2022, then decreased by 12.07% to $813268.0 in 2023, then grew by 5.49% to $857899.0 in 2024, then decreased by 12.87% to $747506.0 in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $747506.0, $1.2 million, and $857899.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 2.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Alpha Tau Medical | 1.21 Bn | 1.11 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 13.74 Mn |
| Dec 31, 2023 | 13.74 Mn |
| Dec 31, 2021 | 13.74 Mn |
| Dec 31, 2021 | 13.74 Mn |
| Dec 31, 2020 | 7.23 Mn |
| Dec 31, 2020 | 7.23 Mn |